By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon
Urodynamic testing is any procedure that evaluates how well the bladder, sphincters, and urethra operate to hold and release urine. The majority of urodynamic tests assess how well the bladder can hold and empty pee.
Urodynamics will evaluate bladder filling, bladder storage, bladder transportation, and urine emptying/micturition.
The purpose of urodynamics is to imitate and determine the reasons for lower urinary tract dysfunction. A computer is used to measure the amount and flow rate automatically, providing a graph that shows any changes. The results of the test will tell the provider if they have weak bladder muscles or a blockage.
The Global Urodynamic Testing system market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Bright Uro, a medical device startup with a purpose to change care for lower urinary tract symptoms (LUTS) through urodynamic breakthroughs, announced the company’s official launch today. The National Institutes of Health also granted Bright Uro a $2 million Phase II SBIR grant (NIH).
Cleveland Clinic has granted Bright Uro an exclusive licensing deal for technology developed in partnership with the Department of Veterans Affairs, Case Western Reserve University, and Parker Hannifin Corporation, which will be used in their exploratory Glean Urodynamics System.
Urodynamic tests are performed on patients who have pee leaks, bladder emptying challenges, urine flow abnormalities, or other lower urinary tract symptoms (LUTS) in order to determine how well the bladder, sphincters, and urethra hold and release urine.
Millions of Americans suffer from LUTS caused by overactive bladder (OAB), benign prostatic hyperplasia (BPH), and other conditions. However, urodynamics is frequently underutilised due to the high cost, inaccuracy, and patient discomfort.
The Glean Urodynamics System from Bright Uro is intended to improve the patient and physician experience by increasing accuracy and comfort.
The comprehensive system offers wireless, catheter-free urodynamics, with the purpose of significantly transforming the standard of care and therapy selection process related with symptoms and disorders of the lower urinary tract.
The Glean system includes an insertion tool, a Bluetooth®-enabled pressure sensor in a flexible silicone tube, a software programme for physicians and patients to use, and a uroflowmetry to detect volume and flow. With greater accuracy and comfort, Bright Uro seeks to improve the patient and physician experience.
